List of Registries

BENLYSTA^™ (belimumab) Pregnancy Registry

If you are pregnant and have been given BENLYSTA^™ within the four months prior to becoming pregnant and/or during pregnancy, you are eligible to participate in this global registry. The pregnant woman or one of her health care providers may contact the registry at:

Toll-free phone number (North America): +1 877 681 6296
Toll-free worldwide access fax number: +1 855 269 6182
Email address: benlysta.pregnancy@ppdi.com
Website: http://pregnancyregistry.gsk.com/benlysta.html

EXPECT - Xolair^® Pregnancy Registry

Pregnant women exposed to Xolair^® within eight weeks prior to conception or at any time during the pregnancy and who are still currently pregnant are eligible to participate in this U.S. registry. They may contact the registry at:

Toll-free phone number: +1 866 4XOLAIR (496 5247) Option 3
Toll-free fax number: +1 877 490 1942

Oseltamivir Safety in Pregnancy

European-based, retrospective, observational, database study assessing the safety of oseltamivir exposure in pregnant women and their offspring.

Email address: pregnancyandinfantregistries@ppdi.com

Zanamivir Safety in Pregnancy

European-based, retrospective, observational, database study assessing the safety of zanamivir (Relenza inhalation powder) exposure in pregnant women and their offspring.

Email address: pregnancyandinfantregistries@ppdi.com